Genomic Valley Biotech Limited (BOM:539206)

Genomic Valley Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	84	179	106	66	76	72
Market Cap Growth	-73.74%	68.80%	59.59%	-12.12%	4.87%	172.52%
Enterprise Value	84	175	106	66	76	87
Last Close Price	27.57	58.59	34.71	21.75	24.75	23.60
PE Ratio	77.68	50.26	698.35	10.25	-	-
PS Ratio	12.69	21.21	64.23	2.44	107.14	34.64
PB Ratio	2.14	4.59	2.99	1.88	2.63	1.61
P/TBV Ratio	2.14	4.59	2.99	1.88	2.63	1.61
P/FCF Ratio	-	993.24	-	-	-	-
P/OCF Ratio	-	658.09	-	-	-	4.86
EV/Sales Ratio	12.68	20.71	63.98	2.44	107.03	41.60
EV/EBITDA Ratio	42.04	39.77	694.00	7.55	-	-
EV/EBIT Ratio	42.71	40.00	747.67	7.62	-	-
EV/FCF Ratio	-	970.03	-	-	-	-
Debt / Equity Ratio	-	-	-	-	-	0.35
Asset Turnover	0.16	0.19	0.04	0.66	0.01	0.03
Quick Ratio	5.49	4.93	3.21	2.53	0.08	0.10
Current Ratio	6.47	5.73	3.68	2.89	5.31	0.19
Return on Equity (ROE)	2.81%	9.57%	0.43%	20.24%	-0.25%	-11.73%
Return on Assets (ROA)	2.90%	6.29%	0.20%	13.25%	-5.00%	-2.59%
Return on Capital (ROIC)	3.18%	7.34%	0.25%	16.99%	-6.40%	-3.22%
Return on Capital Employed (ROCE)	5.00%	11.20%	0.40%	24.70%	-12.70%	-4.80%
Earnings Yield	1.29%	1.99%	0.14%	9.76%	-0.12%	-7.75%
FCF Yield	-	0.10%	-0.19%	-11.72%	-28.17%	-1.31%
Buyback Yield / Dilution	-2.21%	-0.24%	0.70%	1.79%	-1.91%	-0.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.